At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities.
Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand.
You can read more about our editorial policy here.
Recent research shows that the Parkinson’s disease (PD) protein, alpha-synuclein, blocks pro-survival signals from an important brain growth factor. These…